Gretchen Vandal

Gretchen Vandal is an accomplished professional in the field of global regulatory affairs, currently serving as Global Regulatory Lead at Compass Pathways since April 2023. Prior to this role, Gretchen held various leadership positions at Takeda, including Executive Director and Senior Director, where responsibilities encompassed overseeing regulatory strategies for devices and combination products. Experience at Sanofi as Director of Global Regulatory Affairs for Digital Health and Software Medical Devices, along with a tenure at Biogen focusing on digital health-enabling devices, underscores expertise in innovative regulatory strategy development. Earlier career roles at Amgen and Morton Grove Pharmaceuticals involved regulatory affairs management, quality control, and compliance, complemented by a strong educational background with an MBA in International Business and an M.S. in Regulatory Affairs from Northeastern University, as well as a B.S. in Microbiology from the University of Rhode Island.